Jitendra “Jitty” Malik is a partner in the firm's Intellectual Property Litigation Group. Dr. Malik's scientific expertise includes electronic materials, semiconductor processing, adhesive science, polymer chemistry and physics, electrochemistry, organometallic chemistry and biochemistry.

Dr. Malik's practice focuses on patent litigation, opinions, IP due diligence, licensing and prosecution in all areas. Dr. Malik also has experience handling patents that are challenged in the inter partes review process before the USPTO. Dr. Malik has substantial expertise in the drug-approval process under the Hatch-Waxman Act, which includes developing patent strategies to assist clients in marketing drug products, litigating patents under the Hatch-Waxman Act and evaluating competitive patents. Dr. Malik also counsels clients on issues related to biologics, biosimilars, and the new biosimilars pathway. Dr. Malik is a member of the Pharmaceutical and Biotechnology Issues Committee of the Intellectual Property Owners Associations and recently participated in a panel discussion at the Biotechnology Industry Organization meeting where he addressed recent changes to the standards governing inequitable conduct. Dr. Malik also attends conferences related to semiconductor matters.

Prior to attending law school, Dr. Malik was a project supervisor for a leading semiconductor materials manufacturer. Dr. Malik has been published numerous times in scholarly scientific and legal literature.